ERBB2 and breast carcinoma: Breast cancers are diverse and often identified by molecular subtype via immunohistochemical (IHC) expression of prognostic markers: estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2).